RxTE Health Promotes David Henka to Chief Executive Officer

Pharmacy Benefit Solution Provider Announces Company President Will Also Assume Role of CEO

SILICON VALLEY, CA, UNITED STATES - Nov 7, 2017 - RxTE Health (RxTE), a company specializing in pharmacy cost reduction programs for employers, today announced that its president, David Henka, has been promoted to Chief Executive Officer. As CEO, Henka will be responsible for driving the long-term strategic vision of the company and for overseeing product and business development, sales and marketing initiatives and financial operations. Henka will continue to also serve as the company’s president, a position he has held since joining the company in May 2017. 

Prior to this latest promotion, Henka served as the company’s COO where he was responsible for sales and the development of the company’s IT and analytics platform. Henka brings decades of experience consulting with health plan sponsors on a wide range of employee benefit issues to his new role at RxTE. Prior to joining RxTE, Henka served as the Director of the Reta Trust, a nonprofit Catholic employer healthcare trust, where he was responsible for vendor contracting, benefit design, clinical reporting and strategic market planning. Before that, Henka worked for Kaiser Permanente where he served as Director of Strategic Accounts and was responsible for overseeing CalPERS, which is California’s largest pension and health benefits system. Henka holds a Bachelor of Arts in history from the University of California, Los Angeles.

“We are thrilled to promote David to the role of CEO. In the short time he has been with RxTE, he has already demonstrated superior internal leadership skills and external client service capabilities, both of which have helped to strengthen and accelerate our product development roadmap,” said Tom Traylor, member of the RxTE Health board. “We are confident that David will lead RxTE as we continue to grow to meet the increasing demand for our innovative pharmacy benefit solutions.”

RxTE works with employers across the country to implement reference pricing, an innovative payment model proven to significantly move the needle on healthcare’s fastest growing (and third largest) cost driver: pharmaceuticals. Using a propriety algorithm, RxTE leverages insurer/employer contributions and economic incentives to encourage patients to select less expensive drugs that are as therapeutically effective as their name-brand counterparts.

“I’m honored to have been promoted to CEO of RxTE, a company that I truly believe has the vision and the technological capabilities to significantly reduce healthcare costs via solutions that enable greater transparency,” said Henka. “At a time when so much is uncertain in healthcare, I am proud to work for a company that is deploying a drug comparison model that will inevitably bend the cost curve and improve care for all.”

About RxTE Health:

Since 2010, RxTE Health (RxTE) has worked with some of the country’s largest employers across multiple industries, including unions and trusts, to effectively drive down pharmacy costs. RxTE leverages a reference pricing model which applies a proprietary algorithm scientifically proven to drive immediate and ongoing savings of more than 20 percent, while also empowering members and their doctors to select the most cost-effective drug treatment. To start lowering costs, increase benefit plan adherence and improve the well-being of employees, visit www.rxtehealth.com


Media Contact:

Ashley Owen

Aria Marketing for RxTE Health

(617) 332-9999 x 216